Pricing Log in Create free account

Climb Bio, Inc. (CLYM) vs Faeth Therapeutics, Inc. (FTH)

Climb Bio, Inc. and Faeth Therapeutics, Inc. are both Biotechnology companies. Climb Bio, Inc. and Faeth Therapeutics, Inc. are of similar size ($514.8M and $509.5M). Across the 9 metrics below, Climb Bio, Inc. leads on 7 and Faeth Therapeutics, Inc. on 2.

Valuation

Metric CLYM FTH Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 3.27 3.51 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (8.07%) (635.04%) (32.88%)
Free cash flow yield (6.79%) (7.66%) (23.13%)

Profitability

Metric CLYM FTH Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (27.10%) (229.61%) (51.96%)
Return on assets (26.27%) (204.67%) (46.06%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM FTH Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 42.48% 30.33% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLYM FTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.45 16.12 4.97
Net debt to EBITDA 1.44 0.96 1.01

Dividend

Metric CLYM FTH Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLYM FTH Biotechnology median
Market cap 509.46m 514.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack